Malaria is one of the oldest known human diseases, and the Plasmodium genus of parasites
has plagued vertebrates for millions of years. Although five Plasmodium species infect …

Abstract The Malaria Vaccine Technology Roadmap calls for a 2015 landmark goal of a first-
generation malaria vaccine that has protective efficacy against severe disease and death …

A malaria vaccine for mass immunization, which could be delivered cheaply and widely and
provide long lasting protection, would have a massive effect on global public health …

Despite global efforts to control malaria, the illness remains a significant public health threat.
Currently, there is no licensed vaccine against malaria, but an efficacious vaccine would …

Despite recent progress in reducing deaths attributable to malaria, it continues to claim
approximately 500,000 lives per year and is associated with approximately 200 million …

In 2021, nearly half of the world's population lived at risk from malaria, with over 600 000
deaths annually, of which over 95% occur in the WHO African region and 80% of these in …

The first malaria vaccine has been recently approved for children living in malaria-endemic
areas. While this is long-awaited and welcome news, the modest efficacy of the vaccine …

Abstract The Malaria Vaccine Symposium occurred at Johns Hopkins University in
Baltimore, MD, USA on April 25th, 2017, coinciding with World Malaria Day and the WHO …

Malaria vaccine development entered a new era in 2015 when the pre-erythrocytic
Plasmodium falciparum candidate RTS, S was favorably reviewed by the European …

Background The world has made great strides towards beating malaria, although about half
of the world population is still exposed to the risk of contracting malaria. Developing an …